Skip to main content

Closed

CSTL: Castle Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+51.1% / yr

Operating margin-8.1%

ROIC-5.7%

Financially safe

Strong

Debt / equity0.08×

Interest coverage2639.8×

Current ratio6.04×

Castle Biosciences, Inc.

CSTLNASDAQ Global Market·USD·Closed

Castle Biosciences, Inc.

CSTLNASDAQ·USD·Closed

$28.00

+4.52%

$28.00

+$1.21 (4.52%)

52W Range

45thpctl

Volume

4.29×avg

Mkt Cap

849.24MUSD

P/E

-42.5TTM

Div Yield

–ann

52W Range

45thpctl

Volume

4.29×avg

Market Cap

849.24MUSD

P/E Ratio

-42.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings